Orexo AB (ORXOF)
1.44
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Orexo EPS Diluted (Quarterly) : -0.3052 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3052 |
| March 31, 2026 | -0.417 |
| December 31, 2025 | -0.1357 |
| September 30, 2025 | -0.0902 |
| June 30, 2025 | -0.1186 |
| March 31, 2025 | -0.0432 |
| December 31, 2024 | -0.3124 |
| September 30, 2024 | -0.1165 |
| June 30, 2024 | -0.0973 |
| March 31, 2024 | -0.0249 |
| December 31, 2023 | -0.0506 |
| September 30, 2023 | -0.0895 |
| June 30, 2023 | -0.0347 |
| March 31, 2023 | -0.1781 |
| December 31, 2022 | -0.2491 |
| September 30, 2022 | -0.0731 |
| June 30, 2022 | -0.1058 |
| March 31, 2022 | -0.0736 |
| December 31, 2021 | -0.2166 |
| September 30, 2021 | -0.1752 |
| June 30, 2021 | -0.2552 |
| March 31, 2021 | -0.1093 |
| December 31, 2020 | -0.1679 |
| September 30, 2020 | -0.2796 |
| June 30, 2020 | -0.0981 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.2414 |
| December 31, 2019 | 0.1144 |
| September 30, 2019 | 0.3295 |
| June 30, 2019 | 0.1598 |
| March 31, 2019 | 0.0436 |
| December 31, 2018 | 0.1626 |
| September 30, 2018 | 0.1979 |
| June 30, 2018 | 0.167 |
| March 31, 2018 | -0.0924 |
| December 31, 2017 | 0.0925 |
| September 30, 2017 | 0.0994 |
| June 30, 2017 | 0.0102 |
| March 31, 2017 | -0.1121 |
| December 31, 2016 | 0.1064 |
| September 30, 2016 | 0.122 |
| June 30, 2016 | 0.017 |
| March 31, 2016 | -0.1182 |
| December 31, 2015 | -0.1763 |
| September 30, 2015 | -0.1568 |
| June 30, 2015 | -0.2922 |
| March 31, 2015 | -0.0539 |
| December 31, 2014 | 0.1965 |
| September 30, 2014 | -0.1627 |
| June 30, 2014 | -0.2394 |
| March 31, 2014 | -0.1021 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Swedencare AB | 0.0158 |
| Camurus AB | 0.432 |
| Moberg Pharma AB | -0.0075 |
| Infant Bacterial Therapeutics AB | -0.1863 |
| AstraZeneca PLC | 0.9849 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.95M |
| Revenue (Quarterly) | 0.3738M |
| Total Expenses (Quarterly) | 11.32M |
| Enterprise Value | 22.99M |
| Gross Profit Margin (Quarterly) | -137.1% |
| Profit Margin (Quarterly) | -2.93K% |
| Earnings Yield | -65.84% |
| Normalized Earnings Yield | -65.85 |